Silverfin false false 31/12/2025 01/01/2025 31/12/2025 D Donegan 01/12/2021 P L Donegan 01/12/2021 A E Gamon 01/12/2021 19 August 2026 no description of principal activity 13775664 2025-12-31 13775664 bus:Director1 2025-12-31 13775664 bus:Director2 2025-12-31 13775664 bus:Director3 2025-12-31 13775664 2024-12-31 13775664 core:CurrentFinancialInstruments 2025-12-31 13775664 core:CurrentFinancialInstruments 2024-12-31 13775664 core:Non-currentFinancialInstruments 2025-12-31 13775664 core:Non-currentFinancialInstruments 2024-12-31 13775664 core:ShareCapital 2025-12-31 13775664 core:ShareCapital 2024-12-31 13775664 core:RetainedEarningsAccumulatedLosses 2025-12-31 13775664 core:RetainedEarningsAccumulatedLosses 2024-12-31 13775664 core:CostValuation 2024-12-31 13775664 core:AdditionsToInvestments 2025-12-31 13775664 core:DisposalsRepaymentsInvestments 2025-12-31 13775664 core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 13775664 core:CostValuation 2025-12-31 13775664 2023-12-31 13775664 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2025-12-31 13775664 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2024-12-31 13775664 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2025-12-31 13775664 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2024-12-31 13775664 2025-01-01 2025-12-31 13775664 bus:FilletedAccounts 2025-01-01 2025-12-31 13775664 bus:SmallEntities 2025-01-01 2025-12-31 13775664 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 13775664 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 13775664 bus:Director1 2025-01-01 2025-12-31 13775664 bus:Director2 2025-01-01 2025-12-31 13775664 bus:Director3 2025-01-01 2025-12-31 13775664 2024-01-01 2024-12-31 13775664 core:Non-currentFinancialInstruments 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Company No: 13775664 (England and Wales)

MARLIMA LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

MARLIMA LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

MARLIMA LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2025
MARLIMA LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2025
DIRECTORS D Donegan
P L Donegan
A E Gamon
REGISTERED OFFICE 45 Gresham Street
London
EC2V 7BG
United Kingdom
COMPANY NUMBER 13775664 (England and Wales)
ACCOUNTANT S&W Partners LLP
103 Colmore Row
Birmingham
B3 3AG
MARLIMA LIMITED

BALANCE SHEET

As at 31 December 2025
MARLIMA LIMITED

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Fixed assets
Investments 3 15,842,157 14,540,484
15,842,157 14,540,484
Current assets
Debtors 4 5,991 3,234
Cash at bank and in hand 170,603 167,310
176,594 170,544
Creditors: amounts falling due within one year 5 ( 122,902) ( 31,872)
Net current assets 53,692 138,672
Total assets less current liabilities 15,895,849 14,679,156
Creditors: amounts falling due after more than one year 6 ( 12,521,872) ( 12,521,872)
Provision for liabilities 7 ( 710,228) ( 459,919)
Net assets 2,663,749 1,697,365
Capital and reserves
Called-up share capital 100 100
Profit and loss account 2,663,649 1,697,265
Total shareholders' funds 2,663,749 1,697,365

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Marlima Limited (registered number: 13775664) were approved and authorised for issue by the Board of Directors on 19 August 2026. They were signed on its behalf by:

D Donegan
Director
MARLIMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
MARLIMA LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Marlima Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 45 Gresham Street, London, EC2V 7BG, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The functional currency of Marlima Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.

These financial statements are separate financial statements.

Going concern

The financial statements have been prepared on a going concern basis.

The directors have made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise on monetary items.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on enacted or substantively enacted tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 3 3

3. Fixed asset investments

Listed investments Total
£ £
Cost or valuation before impairment
At 01 January 2025 14,540,484 14,540,484
Additions 5,103,799 5,103,799
Disposals ( 5,261,347) ( 5,261,347)
Movement in fair value 1,459,221 1,459,221
At 31 December 2025 15,842,157 15,842,157
Carrying value at 31 December 2025 15,842,157 15,842,157
Carrying value at 31 December 2024 14,540,484 14,540,484

4. Debtors

2025 2024
£ £
Corporation tax 5,459 3,190
Other debtors 532 44
5,991 3,234

5. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 7,303 0
Taxation and social security 81,109 0
Other creditors 34,490 31,872
122,902 31,872

6. Creditors: amounts falling due after more than one year

2025 2024
£ £
Other creditors 12,521,872 12,521,872

There are no amounts included above in respect of which any security has been given by the small entity.

7. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 459,919) ( 142,396)
Charged to the Statement of Income and Retained Earnings ( 250,309) ( 317,523)
At the end of financial year ( 710,228) ( 459,919)

The deferred taxation balance is made up as follows:

2025 2024
£ £
Capital gains and losses ( 710,169) ( 459,919)
Short term timing differences ( 59) 0
( 710,228) ( 459,919)

8. Related party transactions

At the year end, the Company owed the director £12,521,872 (2024 - £12,521,872). This loan is unsecured, interest free and repayable on demand.